Medical Applications of Beta-Glucan

β-Glucan In Treatment Of Low-density Lipoprotein (ldl) Cholesterol

Author(s): Betül Gürünlü

Pp: 53-62 (10)

DOI: 10.2174/9789815039238122010008

* (Excluding Mailing and Handling)


Hypercholesterolemia is one of the most important risk elements of
cardiovascular disease causing metabolic syndrome, diabetes, hypertension. Although
there is a development in this subject, the studies for finding new ways of preventing
and healing dyslipidemia are continuing, and current treatments for cardiovascular
diseases are stimulating different side effects. There are two kinds of β-glucans,
insoluble and soluble. These supplements directly interact with biliary salts and lipids
and in the bowel and decrease the level of cholesterol [1]. The patients having
dyslipidemia can be healed by using the therapeutic effect of β-glucans as they do not
create any significant side effects. In this review, the healing effect of β-glucans on
decreasing cholesterol levels in humans. 

Keywords: β-glucans, Hypercholesterolemia, Low-density Lipoprotein Cholesterol.

Related Journals
Related Books
© 2023 Bentham Science Publishers | Privacy Policy